MetLife Reports Strong Q1 2026 Earnings with Increased Net Income and EPS, Alongside Significant Capital Actions
MET sits 17% above its 52-week low of $67.33.
Summary
MetLife reported strong Q1 2026 financial results with increased net income and EPS, supported by a $1.0 billion subordinated debt issuance and $755 million in share repurchases.
Key Events · Earnings and Guidance · MET
-
Increased Net Income and EPS
Net income available to common shareholders rose to $1,140 million in Q1 2026 from $879 million in Q1 2025, with basic EPS increasing to $1.75 from $1.29.
-
Subordinated Debt Issuance
The company issued $1.0 billion of 5.850% Fixed-to-Fixed Reset Rate Subordinated Debentures due March 2056 in February 2026.
-
Significant Share Repurchases
MetLife repurchased 10,121,118 shares of its common stock for $755 million during Q1 2026, with $1.317 billion remaining under existing authorizations.
-
Improved Effective Tax Rate
The effective tax rate on income before provision for income tax decreased to 23% in Q1 2026 from 30% in Q1 2025.
Analysis · MET · Finance
MetLife's Q1 2026 10-Q filing confirms robust financial performance, building on the positive adjusted EPS reported in the recent 8-K. The company demonstrated substantial year-over-year growth in GAAP net income and basic EPS, indicating strong operational results. Concurrently, MetLife actively managed its capital structure by issuing $1.0 billion in subordinated debt and executing $755 million in common stock repurchases, reflecting a balanced approach to financing and shareholder returns. The improved effective tax rate further contributed to the favorable earnings, reinforcing a positive outlook for the company's financial health.
At the time of this filing, MET was trading at $78.60 on NYSE in the Finance sector, with a market capitalization of approximately $51.4B. The 52-week trading range was $67.33 to $83.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.